Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors - Related Studies

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

This study has been completed.

Study NCT00078845. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Cancer-Related Problem/Condition
		Lung Cancer
		Ovarian Cancer
		Prostate Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Lung Neoplasms
		Ovarian Neoplasms
		Peripheral Nervous System Diseases
		Prostatic Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Breast Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Genital Diseases, Female
		Genital Diseases, Male
		Genital Neoplasms, Female
		Genital Neoplasms, Male
		Gonadal Disorders
		Lung Diseases
		Neoplasms
		Neoplasms by Site
		Nervous System Diseases
		Neuromuscular Diseases
		Ovarian Diseases
		Prostatic Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Skin Diseases
		Thoracic Neoplasms
		Urogenital Neoplasms

4	Interventions listed in this trial
		amifostine trihydrate

5	Additional drug interventions recognized in this trial
		Amifostine

6	More general drug interventions related to this trial
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Radiation-Protective Agents

7	Sponsors listed in this trial
		M.D. Anderson Cancer Center
		National Cancer Institute (NCI)